Hostname: page-component-5db58dd55d-l8wb7 Total loading time: 0 Render date: 2026-05-28T12:34:53.822Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (October 2008)

Published online by Cambridge University Press:  01 July 2009

R. Sutherland
R. Sutherland
Affiliation:
Cancer Research ProgramGarvan Institute of Medical ResearchDarlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Journals Watch
Information
Breast Cancer Online , Volume 12 , Issue 7 , July 2009 , e11
Copyright
Copyright © Cambridge University Press 2009

References

1.Beetstra, S, Suthers, G, Dhillon, V, Salisbury, C, Turner, J, Altree, M, McKinnon, R, Fenech, M. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2565–2571.CrossRefGoogle Scholar
2.Bempt, IV, Van Loo, P, Drijkoningen, M, Neven, P, Smeets, A, Christiaens, MR, Paridaens, R, De Wolf-Peeters, C. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing. J Clin Oncol 2008; 26: 4869–4874.CrossRefGoogle Scholar
3.Bouras, T, Pal, B, Vaillant, F, Harburg, G, Asselin-Labat, ML, Oakes, SR, Lindeman, GJ, Visvader, JE. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008; 3: 429–441.CrossRefGoogle ScholarPubMed
4.Castro-Rivera, E, Ran, S, Brekken, RA, Minna, JD. Semaphorin 3B inhibits the Phosphatidylinositol 3-Kinase/Akt Pathway through Neuropilin-1 in lung and breast cancer cells. Cancer Res 2008; 68: 8295–8303.CrossRefGoogle ScholarPubMed
5.Conzen, SD. Nuclear receptors and breast cancer. Mol Endocrinol 2008; 22: 2215–2228.CrossRefGoogle ScholarPubMed
6.Davis, VL, Jayo, MJ, Ho, A, Kotlarczyk, MP, Hardy, ML, Foster, WG, Hughes, CL. Black Cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer Res 2008; 68: 8377–8383.CrossRefGoogle ScholarPubMed
7.DuSell, CD, McDonnell, DP. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. Trends Pharmacol Sci 2008; 29: 510–514.CrossRefGoogle ScholarPubMed
8.Eisen, A, Lubinski, J, Gronwald, J, Moller, P, Lynch, HT, Klijn, J, Kim-Sing, C, Neuhausen, SL, Gilbert, L, Ghadirian, P, Manoukian, S, Rennert, G, Friedman, E, Isaacs, C, Rosen, E, Rosen, B, Daly, M, Sun, P, Narod, SAHormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 2008; 100: 1361–1367.CrossRefGoogle ScholarPubMed
9.Ellis, MJ, Tao, Y, Luo, JQ, A’Hern, R, Evans, DB, Bhatnagar, AS, Ross, HAC, von Kameke, A, Miller, WR, Smith, I, Eiermann, W, Dowsett, M. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst 2008; 100: 1380–1388.CrossRefGoogle ScholarPubMed
10.Fabre, A, Fournier, A, Mesrine, S, Gompel, A, Desreux, J, Berrino, F, Boutron-Ruault, MC, Romieu, I, Clavel-Chapelon, F. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors. Cancer Epidemiol Biomarkers Prev 2008; 17: 2723–2728.CrossRefGoogle ScholarPubMed
11.Firlej, V, Ladam, F, Brysbaert, G, Dumont, P, Fuks, F, de Launoit, Y, Benecke, A, Chotteau-Lelievre, A. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J Cell Sci 2008; 121: 3393–3402.CrossRefGoogle ScholarPubMed
12.Gaudet, MM, Chanock, S, Dunning, A, Driver, K, Brinton, LA, Lissowska, J, Peplonska, B, Pharoah, P, Garcia-Closas, M. HSD17B1 genetic variants and hormone receptor-defined breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2766–2772.CrossRefGoogle ScholarPubMed
13.Ginsburg, OM, Martin, LJ, Boyd, NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008; 99: 1369–1374.CrossRefGoogle ScholarPubMed
14.Green, CA, Peter, MB, Speirs, V, Shaaban, AM. The potential role of ER β isoforms in the clinical management of breast cancer. Histopathology 2008; 53: 374–380.CrossRefGoogle ScholarPubMed
15.Guerra, E, Trerotola, M, Dell’Arciprete, R, Bonasera, V, Palombo, B, El-Sewedy, T, Ciccimarra, T, Crescenzi, C, Lorenzini, F, Rossi, C, Vacca, G, Lattanzio, R, Piantelli, M, Alberti, S. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 2008; 68: 8113–8121.CrossRefGoogle ScholarPubMed
16.Haibe-Kains, B, Desmedt, C, Sotiriou, C, Bontempi, G. A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Bioinformatics 2008; 24: 2200–2208.CrossRefGoogle Scholar
17.Howe, LR, Lippman, SM. Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst 2008; 100: 1420–1423.CrossRefGoogle ScholarPubMed
18.Hwang, KT, Han, W, Cho, J, Lee, JW, Ko, E, Kim, EK, Jung, SY, Jeong, EM, Bae, JY, Kang, JJ, Yang, SJ, Kim, SW, Noh, DY. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 2008; 123: 1807–1815.CrossRefGoogle ScholarPubMed
19.John, S, Nayvelt, I, Hsu, HC, Yang, PA, Liu, WS, Das, GM, Thomas, T, Thomas, TJ. Regulation of estrogenic effects by Beclin 1 in breast cancer cells. Cancer Res 2008; 68: 7855–7863.CrossRefGoogle ScholarPubMed
20.Kabil, A, Silva, E, Kortenkamp, A. Estrogens and genomic instability in human breast cancer cells – involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis 2008; 29: 1862–1868.CrossRefGoogle ScholarPubMed
21.Katsuno, Y, Hanyu, A, Kanda, H, Ishikawa, Y, Akiyama, F, Iwase, T, Ogata, E, Ehata, S, Miyazono, K, Imamura, T,. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 2008; 27: 6322–6333.CrossRefGoogle ScholarPubMed
22.Kavanagh, AM, Byrnes, GB, Nickson, C, Cawson, JN, Giles, GG, Hopper, JL, Gertig, DM, English, DR. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev 2008; 17: 2818–2824.CrossRefGoogle ScholarPubMed
23.Leary, RJ, Lin, JC, Cummins, J, Boca, S, Wood, LD, Parsons, DW, Jones, S, Sjoblom, T, Park, BH, Parsons, R, Willis, J, Dawson, D, Willson, JKV, Nikolskaya, T, Nikolsky, Y, Kopelovich, L, Papadopoulos, N, Pennacchio, LA, Wang, TL, Markowitz, SD, Parmigiani, G, Kinzler, KW, Vogelstein, B, Velculescu, VE. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 2008; 105: 16224–16229.CrossRefGoogle ScholarPubMed
24.Liapis, E, McLuckie, KIE, Lewis, PD, Farmer, PB, Brown, K. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots. Nucleic Acids Res 2008; 36: 5933–5945.CrossRefGoogle ScholarPubMed
25.Linos, E, Spanos, D, Rosner, BA, Linos, K, Hesketh, T, Qu, JD, Gao, YT, Zheng, W, Colditz, GA. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst 2008; 100: 1352–1360.CrossRefGoogle Scholar
26.Marlow, R, Strickland, P, Lee, JS, Wu, XY, PeBenito, M, Binnewies, M, Le, EK, Moran, A, Macias, H, Cardiff, RD, Sukumar, S, Hinck, L. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 2008; 68: 7819–7827.CrossRefGoogle ScholarPubMed
27.Mazan-Mamczarz, K, Hagner, PR, Dai, BJ, Wood, WH, Zhang, YQ, Becker, KG, Liu, ZQ, Gartenhaus, RB. Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res 2008; 68: 7730–7735.CrossRefGoogle Scholar
28.Miller, JK, Shattuck, DL, Ingalla, EQ, Yen, LL, Borowsky, AD, Young, LJT, Cardiff, RD, Carraway, KL, Sweeney, C. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res 2008; 68: 8286–8294.CrossRefGoogle ScholarPubMed